Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas Thermo Fisher Scientific and Illumina, Inc.(NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct... Read more

QIAGEN adds to growth momentum in next-generation sequencing with 2018 plans for significant portfolio enhancements

Goal set to exceed $140 million of NGS-related sales in 2018, up from over $115 million in 2017 New Enterprise Genomics Services to offer gene panel customization capabilities to customers GeneReader NGS System plans include enhanced chemistry, more powerful gene panels Hilden, Germany, and Germantown, Maryland, January 8, 2018 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt... Read more

New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test

New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test Real-Time PCR workflow gains AOAC-RI approval for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, Dec. 5, 2017 /PRNewswire/ — Poultry and pork producers can now rapidly screen for... Read more

MEP Instruments to become Metrohm Australia, Metrohm New Zealand

11/27/2017 In response to changes in the ownership structure of the company and the successful expansion of its business operation, MEP Instruments will change its name to Metrohm Australia and Metrohm New Zealand. Effective 1 January 2018, the distributor of analytical technology solutions will be operating under the name of Metrohm, its sole parent company.... Read more

Promega Maxwell® Modular Automated Nucleic Acid Preparation System Allows Customized Workflows for Labs of All Sizes

MADISON, WI USA (November 14, 2017) A modular automated liquid handling and purification system developed by Promega Corporation for its Maxwell® nucleic acid preparation offersgives labs new found flexibility compared to large all-in-one instruments. The configurable system, which launched this week, works with existing Promega Maxwell® RSC instruments with a software upgrade and introduces two new... Read more

Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017.  The presentation will be webcast live... Read more

Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017.  The presentation will be webcast live... Read more

Fluxion Biosciences Appoints Harvard Bioscience as North American Distributor

      Harvard Bioscience will distribute the IonFlux and BioFlux Systems, targeting the electrophysiology and live cell imaging markets SAN FRANCISCO, Nov. 14, 2017 /PRNewswire/ — Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with Harvard Biosciences. The... Read more

QIAGEN celebrates surpassing 2,000 cumulative placements of QIAsymphony

Outstanding and unmatched capabilities fuel strong growth in installed base and consumables use on highly versatile Sample to Insight automation solution Hilden, Germany, and Germantown, Maryland, November 13, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories... Read more

QIAGEN and ICMP launch next-generation DNA testing solutions for identifying missing persons

The Hague, 24 October 2017 – The International Commission on Missing Persons (ICMP) today announced the launch of a cutting-edge next-generation sequencing (NGS) workflow created in collaboration with QIAGEN N.V. for ICMP’s missing persons DNA identification laboratory in The Hague. The solution integrates QIAGEN’s GeneReader NGS System and spans all aspects of the DNA laboratory workflow, from... Read more